EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pralidoxime Is No Longer Fit for Purpose as an Antidote to Organophosphate Poisoning in the United Kingdom

George Corby iD

Disaster Medicine and Public Health Preparedness · 2024

DOI: 10.1017/dmp.2024.25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disaster Medicine and Public Health Preparedness, 2024. Verfasst von George Corby. Beteiligte Einrichtung: St John's College, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Organophosphate Poisoning, Cholinesterase Reactivators, Pralidoxime Compounds. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pralidoxime is the only oxime antidote to organophosphate poisoning stocked in the United Kingdom, produced by rational drug design in the 1950s. Typically, it is used alongside atropine, to reverse the effects of acetylcholinesterase inhibition. However, its efficacy has been questioned by recent meta-analyses of use treating attempted suicides in less economically developed countries, where organophosphate poisoning is more common. This policy analysis assesses the likely efficacy of pralidoxime in the United Kingdom, in scenarios largely different from those evaluated in meta-analyses. In all scenarios, the UK delay in antidote administration poses a major problem, as pralidoxime acts in a time-critical reactivation mechanism before “ageing” of acetylcholinesterase occurs. Additionally, changes in the organophosphates used today versus those pralidoxime was rationally designed to reverse, have reduced efficacy since the 1950s. Finally, the current dosage regimen may be insufficient. Therefore, one must re-evaluate our preparedness and approach to organophosphate poisoning in the United Kingdom.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Organophosphate PoisoningCholinesterase ReactivatorsPralidoxime CompoundsHumansAntidotesAcetylcholinesterase

Stichwörter der Autor:innen

cholinesterase reactivatorsorganophosphatesorganophosphorous compoundsoximespralidoxime compounds

Substanzen

pralidoximeAntidotesAcetylcholinesteraseCholinesterase ReactivatorsPralidoxime Compounds

Autor:innen und Institutionen

  • St John's College, University of Oxford, Oxford, UK.

ORCID-Profile: George Corby

Zitieren

APA

Corby, G. (2024). Pralidoxime Is No Longer Fit for Purpose as an Antidote to Organophosphate Poisoning in the United Kingdom. Disaster Medicine and Public Health Preparedness. https://doi.org/10.1017/dmp.2024.25

Vancouver

Corby G. Pralidoxime Is No Longer Fit for Purpose as an Antidote to Organophosphate Poisoning in the United Kingdom. Disaster Medicine and Public Health Preparedness. 2024. doi:10.1017/dmp.2024.25

BibTeX
@article{Corby2024,
  author = {Corby, George},
  title = {Pralidoxime Is No Longer Fit for Purpose as an Antidote to Organophosphate Poisoning in the United Kingdom},
  journal = {Disaster Medicine and Public Health Preparedness},
  year = {2024},
  doi = {10.1017/dmp.2024.25}
}
Kostenlos starten →